Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study

This study aimed to investigate thrombin-activatable fibrinolysis inhibitor (TAFI) Thr325Ile polymorphism and TAFI antigen (Ag) levels in breast cancer (BC) in the Egyptian population to clarify their role in relation to BC. A group of 300 females was recruited in this study; of these 150 unrelated...

Descripción completa

Detalles Bibliográficos
Autores principales: Fawzy, Manal S., Mohammed, Eman A., Ahmed, Amal S., Fakhr-Eldeen, Abeer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398808/
https://www.ncbi.nlm.nih.gov/pubmed/25893174
http://dx.doi.org/10.1016/j.mgene.2015.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398808/
https://www.ncbi.nlm.nih.gov/pubmed/25893174
http://dx.doi.org/10.1016/j.mgene.2015.03.004

Ejemplares similares